Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, ON, M5S 3E2, Canada.
Stem Cell Res Ther. 2024 Mar 14;15(1):79. doi: 10.1186/s13287-024-03679-3.
The discovery of material transfer between transplanted and host mouse photoreceptors has expanded the possibilities for utilizing transplanted photoreceptors as potential vehicles for delivering therapeutic cargo. However, previous research has not directly explored the capacity for human photoreceptors to engage in material transfer, as human photoreceptor transplantation has primarily been investigated in rodent models of late-stage retinal disease, which lack host photoreceptors.
In this study, we transplanted human stem-cell derived photoreceptors purified from human retinal organoids at different ontological ages (weeks 10, 14, or 20) into mouse models with intact photoreceptors and assessed transfer of human proteins and organelles to mouse photoreceptors.
Unexpectedly, regardless of donor age or mouse recipient background, human photoreceptors did not transfer material in the mouse retina, though a rare subset of donor cells (< 5%) integrated into the mouse photoreceptor cell layer. To investigate the possibility that a species barrier impeded transfer, we used a flow cytometric assay to examine material transfer in vitro. Interestingly, dissociated human photoreceptors transferred fluorescent protein with each other in vitro, yet no transfer was detected in co-cultures of human and mouse photoreceptors, suggesting that material transfer is species specific.
While xenograft models are not a tractable system to study material transfer of human photoreceptors, these findings demonstrate that human retinal organoid-derived photoreceptors are competent donors for material transfer and thus may be useful to treat retinal degenerative disease.
在移植和宿主小鼠光感受器之间发现物质转移,拓宽了利用移植光感受器作为传递治疗性货物的潜在载体的可能性。然而,以前的研究并未直接探索人光感受器进行物质转移的能力,因为人光感受器移植主要在晚期视网膜疾病的啮齿动物模型中进行研究,这些模型缺乏宿主光感受器。
在这项研究中,我们将源自人视网膜类器官的不同胚胎年龄(10、14 或 20 周)的人干细胞衍生光感受器移植到具有完整光感受器的小鼠模型中,并评估人蛋白和细胞器向小鼠光感受器的转移。
出乎意料的是,无论供体年龄或小鼠受体背景如何,人光感受器在小鼠视网膜中均未发生物质转移,尽管有一小部分供体细胞(<5%)整合到了小鼠光感受器细胞层中。为了研究物种障碍是否阻碍了转移,我们使用流式细胞术分析在体外进行物质转移的可能性。有趣的是,分离的人光感受器在体外彼此传递荧光蛋白,但在人源和鼠源光感受器的共培养物中未检测到转移,表明物质转移具有物种特异性。
虽然异种移植模型不是研究人光感受器物质转移的可行系统,但这些发现表明,源自人视网膜类器官的光感受器是物质转移的有效供体,因此可能对治疗视网膜退行性疾病有用。